Management of Coexisting Cataracts and Age-Related Macular Degeneration
Proceed with cataract surgery when visually significant cataracts coexist with AMD, as surgery improves visual acuity without increasing the risk of AMD progression. 1
Cataract Surgery Decision-Making in AMD Patients
The primary concern when these conditions coexist is whether cataract surgery will worsen underlying AMD. The evidence clearly addresses this:
- Cataract surgery does not increase the risk of AMD progression and should be performed when cataracts are visually significant. 1
- Visual acuity improves significantly at 6-12 months post-surgery, with gains of 6.5-7.5 letters compared to unoperated eyes. 2
- The risk of progression to exudative (wet) AMD after cataract surgery is not increased, with no significant difference between operated and unoperated eyes. 3, 2
Specific Management Algorithm
For Cataract Management:
- Perform cataract surgery when cataracts cause visually significant impairment, regardless of AMD presence. 3, 1
- Reassure patients that surgery will not accelerate their AMD. 1
- Vision-related quality of life improves significantly after cataract surgery in AMD patients. 3
For AMD Management:
- Treat exudative (wet) AMD with anti-VEGF therapy regardless of cataract status. 4
- Anti-VEGF injections (intravitreal) represent the best available treatment for wet AMD. 4
- Treatment requires repeated intravitreal injections with ongoing monitoring. 4
Critical Post-Surgical Monitoring
Vigilant follow-up after cataract surgery is essential, not because surgery increases AMD risk, but because the natural progression rate of AMD remains high. 1
- Patients with intermediate AMD or advanced AMD in the fellow eye have high natural progression rates to late AMD. 1
- Monitor specifically for signs of choroidal neovascularization development. 1
- Early detection allows prompt initiation of anti-VEGF therapy if wet AMD develops. 1
Common Pitfalls to Avoid
- Do not delay cataract surgery due to fear of AMD progression—this concern is not supported by evidence. 1
- Do not assume visual improvement from cataract surgery alone will be sufficient if wet AMD is present or develops—anti-VEGF therapy is still required. 4
- Ensure appropriate referral timing to ophthalmology for both conditions, as PCPs play a critical role in early identification. 5